Vimarsana
Biggest News Aggregation in the World

Page 17 - Clinical Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Clinical Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Clinical Program Today - Breaking & Trending Today

Veteran's wife running Boston Marathon for Home Base - Vimarsana News

Veteran's wife running Boston Marathon for Home Base

"I've seen how much they can help. I've seen the difference that they make."

Source: wcvb.com
Gritstone Bio Inc (GRTS) Reports Q3 2023 Financial Results and Progress in Vaccine Development - Vimarsana News

Gritstone Bio Inc (GRTS) Reports Q3 2023 Financial Results and Progress in Vaccine Development

Advancements in COVID-19 and Cancer Vaccine Programs Amid Increased R&D Spending

Source: yahoo.com
Precigen Reports Third Quarter 2023 Financial Results and Progress of Clinical Programs - Vimarsana News

Precigen Reports Third Quarter 2023 Financial Results and Progress of Clinical Programs

– Based on FDA confirmation in August 2023 that the ongoing Phase 1/2 single-arm study of PRGN-2012 in RRP will serve as the pivotal study to support BLA...

Evolus Reports Record Third Quarter 2023 Financial Results and Phase II Data for Extra-Strength 40U - Vimarsana News

Evolus Reports Record Third Quarter 2023 Financial Results and Phase II Data for Extra-Strength 40U

Record Quarterly Net Revenue of $50 Million for Q3 2023, Up 48% from Q3 2022Raises Full-Year 2023 Net Revenue Guidance from $185 to $195 Million to $194 to $198 MillionOperating Use of Cash in Q3 of $0.9 Million, Demonstrating Continued Progress Towards Achieving Profitability1 with Existing Liquidity“Extra-Strength...

Evolus Reports Record Third Quarter 2023 Financial Results and Phase II Data for Extra-Strength 40U Formulation of Jeuveau® - Vimarsana News

Evolus Reports Record Third Quarter 2023 Financial Results and Phase II Data for Extra-Strength 40U Formulation of Jeuveau®

Record Quarterly Net Revenue of $50 Million for Q3 2023, Up 48% from Q3 2022 Raises Full-Year 2023 Net Revenue Guidance from $185 to $195 Million to $194 to $198 Million Operating Use of Cash...